Coagulation inhibitor substitution during sepsis
- 1 November 1995
- journal article
- review article
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 21 (2), S264-S268
- https://doi.org/10.1007/bf01740765
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2Intensive Care Medicine, 1993
- The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons.JCI Insight, 1993
- Treatment of patients with disseminated intravascular coagulation by protein CAmerican Journal of Hematology, 1990
- Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremiaThe American Journal of Medicine, 1989
- Therapeutic Use of Antithrombin III in Shock and Disseminated Intravascular CoagulationSeminars in Thrombosis and Hemostasis, 1989
- Pathophysiologic and Biochemical Events in Disseminated Intravascular Coagulation: Dysregulation of Procoagulant and Anticoagulant PathwaysSeminars in Thrombosis and Hemostasis, 1989
- Heparin Promotes the Inactivation of Antithrombin by Neutrophil ElastaseScience, 1987
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.JCI Insight, 1987
- Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infectionsEuropean Journal of Haematology, 1987
- Substitution therapy with an antithrombin III concentrate in shock and DICThrombosis Research, 1982